Case report - Sirolimus rescue therapy for refractory renal allograft rejection

Transplantation

Volumn 61, Issue 6, 1996, Pages 977-979

  Slaton, Joel W ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DRUG POTENCY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; OLIGURIA; PRIORITY JOURNAL; PROPHYLAXIS; URINE VOLUME;

CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MUROMONAB-CD3; POLYENES; SIROLIMUS;

EID: 0029921710     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603270-00025     Document Type: Article

References (18)

1. Takahara S, Moutabarrik A, Kokado Y, et al. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients. Transplant Proc 1993; 25: 2254.
2. Sollinger HW, Belzer FO, Deierhoi M, et al. RS-61443: rescue therapy in refractory kidney transplant rejection. Transplant Proc 1993; 25: 698.
3. Teraoka S, Babazono T, Koike T, et al. Effect of rescue therapy using FK506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 1995; 27: 1335.
4. Jordan ML, Shapiro R, Vivas CA, et al. FK506 "rescue therapy" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 6: 860.
5. Dumont FJ, Starvch MJ, Koprak SL, et al. Distinct mechanisms of suppression of murine T cell activation by related macrolides FK506 and rapamycin. J Immunol 1990; 144: 251.
6. Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation. Transplantation 1991; 51: 22.
7. Wang M-E, Stepkowski SM, Ferraresso M, Kahan BD. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats. Transplantation 1992; 54: 704.
8. Chen H, Wu J, Xu D, Luo H, Daloze P. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat. Transplant Proc 1993; 25: 719.
9. Grevel J, Welsh MS, Kahan BD. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough monitoring. Ther Drug Monit 1989; 11: 246.
10. Napoli KL, Kahan BD. Sample clean-up and high performance liquid chromatography techniques for measurement of whole blood rapamycin concentrations. J Chromatogr 1994; 654: 111.
11. Bell PRF, Briggs JD, Calman KC, et al. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet 1971; 1: 876.
12. Ortho Multicenter Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985; 313: 337.
13. Deierhoi MH, Barber WH, Curtis JJ, et al. A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection. Am J Kidney Dis 1988; 11: 86.
14. Mochon M, Kaiser B, Palmer JA, et al. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants. Pediatr Nephrol 1993; 7: 259.
15. Tesi RJ, Elkhammas EA, Henry ML, Ferguson RM. OKT3 for primary therapy of the first rejection episode in kidney transplants. Transplantation 1993; 55: 23.
16. Murgia MG, Kahan BD. Sirolimus adversely affects lipid profile but neither renal allograft function nor hypertension in stable renal transplant patients. Kidney Int 1996; 49: 209.
17. Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Chou T-C. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991; 51: 232.
18. Knight R, Ferraresso M, Serino F, Katz S, Lewis R, Kahan BD. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model. Transplantation 1993; 55: 947.